Scientists believe marijuana-laced chewing gum can treat irritable bowel syndrome

By  ,  Onlymyhealth editorial team
Jan 23, 2017
Comment

Subscribe for daily wellness inspiration

Like onlymyhealth on Facebook!

Irritable bowel syndrome or IBS is a common condition that affects people across the world. A majority of these people are women who are between the age group of 18 and 40. Some of the common symptoms experienced by people suffering from IBS include diarrhea, constipation, abdominal cramps and excess bloating.

 

marijuanainsidse

Image source : Shutterstock

According to a new study, marijuana-laced chewing gum can cure irritable bowel syndrome, reduce painful stomach cramps, control bloating and normalise stool.



The study was conducted by the researchers from Wageningen University in the Netherlands claims CBD. Researchers believe that  marijuana has a property that  could ease the colon spasms that seem to be the root cause of symptoms.



We are excited to see that Axim Biotechnologies Inc (AXIM) has reached another milestone in its clinical development program," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc.



"This is the first advancement in cannabinoid research for treatment of IBS in medical history and gives a clear example of how far ahead AXIM is in its clinical development programs," Titus added.



The study claims itself to be first of its kind to test a relationship between CBD and IBS.



From next month, the trial will begin, testing a cannabis-infused chewing gum made by US firm Medical Marijuana Inc.



They will give trial to 40 participants, aged between 18 and 65, alongside matching placebo gums.



The gum will contain 50mg of CBD per serving and the participants will be allowed up to six chewing gums a day to control their stomach cramps, bloating, pain and other symptoms.



Preliminary research suggests the product could reduce painful stomach cramps, control bloating, and normalize stool.

 

"The cost to society in terms of direct medical expenses and indirect costs associated with loss of productivity and work absenteeism tied to IBS is considerable," Dr Titus stated.



The study reveals that the drug would interact with the endogenous cannabinoid receptors in sufferers' digestive tract, loosening tension.



Specifically, it will test a new product called Can Chew, developed my AXIM Biotechnologies, Medical Marijuana Inc's major investment company.

 

Top Image source : Shutterstock

Health News Source : ANI

Read more articles on Health News

 

Write a Review
Is it Helpful Article?YES236 Views 0 Comment
Post a Comment
disclaimer

Though all possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; Onlymyhealth assumes no liability for the same. Using any information of this website is at the viewers’ risk. Please be informed that we are not responsible for advice/tips given by any third party in form of comments on article pages . If you have or suspect having any medical condition, kindly contact your professional health care provider.

MORE FOR YOU
  • All
  • Article
  • Slideshow
  • Video
  • QnA